50
total announcements
INDIAGLYCO.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 21 Oct 2026
Market Cap
₹2,140 Cr
P/E (TTM)
6.5
EPS (TTM)
₹49.39
52W Low
₹217.00
52W High
₹1,222.00
Dividend Yield
2.35%
Beta
0.35
Price / Book
0.7
Debt / Equity
57.6
Revenue (TTM)
₹4,301 Cr
Gross Margin
35.70%
Operating Margin
11.24%
India Glycols Ltd
India Glycols Ltd has announced the submission of a newspaper advertisement regarding the special window for transfer and dematerialization of physical shares, as per SEBI regulations. Additionally, a tender notice for the resolution of Krishnaganga Spinning Mills Private Limited has been published by Bengaluru Co-operative Milk Union Ltd.
India Glycols Ltd
India Glycols Ltd has received a GST order from the State Tax Officer, SGST Department, Uttarakhand, levying a penalty of Rs. 6,22,080/- for an oversight in E-way bill updation. The company has deposited the penalty amount and will file an appeal against the order.
India Glycols Ltd
India Glycols Ltd clarified on the movement in its share price, stating that it is market-driven and not due to any undisclosed material information. The company reiterated its commitment to comply with regulatory requirements and to disclose material information to the stock exchanges.
India Glycols Ltd
The BSE has sought clarification from India Glycols Ltd regarding significant price movement, to ensure investors have relevant information and to safeguard their interests.
India Glycols Ltd
India Glycols Ltd has issued a communication to its shareholders regarding the apportionment of cost of acquisition of equity shares of the company and its demerged entities, Ennature Bio Pharma Ltd and IGL Spirits Ltd, following a scheme of arrangement.
India Glycols Ltd
India Glycols Ltd has updated on the mode of Analyst / Institutional Investor meetings scheduled on 7th and 8th October, 2026, changing it from In-Person to virtual.
India Glycols Ltd
India Glycols Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended 30th September 2026.
India Glycols Ltd
India Glycols Ltd has announced the schedule of an Analyst/Institutional Investor Meeting on October 7-8, 2026, in Mumbai. The meeting will be held in-person and via roadshow, and discussions will be based on publicly available information.
India Glycols Ltd
India Glycols Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the quarter and half year ending September 30, 2026.
India Glycols Ltd
India Glycols Ltd has announced the schedule of its Analyst/Institutional Investor meeting, to be held on September 28th and 29th in Singapore. The meeting will be based on publicly available information and no unpublished price sensitive information will be discussed.
India Glycols Ltd
India Glycols Ltd has announced a plant visit for investors/analysts on September 19th and 20th, 2026, at Kashipur and Dehradun locations, respectively. The event is in compliance with SEBI Listing Regulations and will not involve the discussion of unpublished price sensitive information.
India Glycols Ltd
India Glycols Ltd has submitted a revised investor presentation due to a typographical error, which is now available on the company's website.
India Glycols Ltd
India Glycols Ltd has announced a demerger of its business into two separate entities: IGL Spirits Ltd and Ennature Ltd, with IGL retaining Biobased Specialty Materials, Sustainable & Performance Chemicals, and Gases, while IGL Spirits will house Potable Spirits & Biofuels, and Ennature will have Nutraceuticals, plant-based APIs, and Biopolymers. The demerger aims to unlock shareholder value through sharper business focus and improved capital allocation.
India Glycols Ltd
India Glycols Ltd has announced an investor presentation for an analyst/institutional investor meeting, highlighting the growth of its Potable Spirits segment and the new Bio-fuels segment, which demonstrated a 100% revenue growth.
India Glycols Ltd
India Glycols Ltd has disclosed an investor presentation for Ennature Biopharma, highlighting the company's natural health and wellness business, including its botanical ingredients portfolio and nutraceutical segment.
India Glycols Ltd
India Glycols Ltd has informed about the change in senior managerial personnel due to the transfer of employment to resulting companies post the Scheme of Arrangement.
India Glycols Ltd
India Glycols Ltd has announced the effectiveness of its Scheme of Arrangement, demerging into three separate entities: India Glycols Ltd, IGL Spirits Ltd, and Ennature Bio Pharma Ltd. Shareholders will receive shares in each of the new entities. The demerger aims to create separate companies with clear business focus, enabling improved management oversight and resource allocation.
India Glycols Ltd
India Glycols Ltd has announced a schedule of analyst/institutional investor meeting on September 2nd, 2026, in Mumbai. The meeting will be a physical group meeting and will be based on publicly available information. No unpublished price sensitive information will be discussed.
India Glycols Ltd
India Glycols Ltd has announced the appointment of new directors and key managerial personnel, including a chairman and managing director, as part of a scheme of arrangement. The appointments are subject to shareholder approval.
India Glycols Ltd
India Glycols Ltd has announced a material update in connection with Ennature Bio Pharma Limited, a Scheme of Arrangement amongst India Glycols Limited and Ennature Bio Pharma Limited, and IGL Spirits Limited and their respective shareholders. The Board of Directors of India Glycols Limited has approved the appointment of six new directors and key managerial personnel, including a Managing Director and four Independent Directors. The appointments are subject to shareholder approval.